Clinical Trial Update: Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating mitomycin C intravesical chemotherapy with Synergo radiofrequency-induced hyperthermia for Bacillus Calmette-Guérin-unrespo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma in Situ of Bladder
• Urinary Bladder Cancer

Drugs mentioned

• Mitomycin C intravesical chemotherapy (mitomycin C)
• Synergo

Snippet

Sponsor: Medical Enterprises Ltd. | Conditions: Bladder Cancer, Bladder Neoplasm | Phase 3 | Status: TERMINATED